Pharmacokinetics Of Vancomycin In Patients Undergoing Continuous Hemodiafiltration
暂无分享,去创建一个
N. Matsuda | S. Gando | K. Iseki | T. Hirano | Yasuko Ito | T. Kameue | Kazuaki Yagasaki
[1] J. Goebel,et al. Hemodiafiltration for vancomycin overdose in a neonate with end-stage renal failure , 1999, Pediatric Nephrology.
[2] P. Palevsky,et al. Determinants of vancomycin clearance by continuous venovenous hemofiltration and continuous venovenous hemodialysis. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[3] A. Wilson,et al. Comparative safety of teicoplanin and vancomycin. , 1998, International journal of antimicrobial agents.
[4] M. Munar,et al. Cyclosporine and Vancomycin Disposition During Continuous Venovenous Hemodiafiltration , 1995, The Annals of pharmacotherapy.
[5] E. Lee,et al. Pharmacokinetics of Intravenous Vancomycin in Patients with End‐Stage Renal Failure , 1990, Therapeutic drug monitoring.
[6] G. Matzke,et al. Clinical Pharmacokinetics of Vancomycin , 1986, Clinical pharmacokinetics.
[7] B. Guery,et al. Pharmacokinetics of vancomycin during continuous hemodiafiltration , 2005, Intensive Care Medicine.
[8] B. Molitoris,et al. Therapeutic drug monitoring in patients with chronic renal failure: evaluation of the Abbott TDx drug assay system. , 1986, American journal of nephrology.
[9] R. Moellering. Pharmacokinetics of vancomycin. , 1984, The Journal of antimicrobial chemotherapy.
[10] T Nakagawa,et al. A pharmacokinetic analysis program (multi) for microcomputer. , 1981, Journal of pharmacobio-dynamics.